Combination recombinant interleukin-2, recombinant interferon-alpha, and 5-fluorouracil for treatment of metastatic renal cell carcinoma

Am J Clin Oncol. 1995 Aug;18(4):358-62. doi: 10.1097/00000421-199508000-00017.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Renal Cell / secondary*
  • Carcinoma, Renal Cell / surgery
  • Carcinoma, Renal Cell / therapy*
  • Fluorouracil / therapeutic use*
  • Humans
  • Interferon Type I / therapeutic use*
  • Interleukin-2 / therapeutic use*
  • Kidney Neoplasms / surgery
  • Kidney Neoplasms / therapy*
  • Male
  • Middle Aged
  • Recombinant Proteins / therapeutic use

Substances

  • Interferon Type I
  • Interleukin-2
  • Recombinant Proteins
  • Fluorouracil